Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People’s Republic of China, and internationally. More Details
Excellent balance sheet and slightly overvalued.
Share Price & News
How has Meilleure Health International Industry Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2327 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 2327's weekly volatility (7%) has been stable over the past year.
7 Day Return
HK Trade Distributors
1 Year Return
HK Trade Distributors
Return vs Industry: 2327 underperformed the Hong Kong Trade Distributors industry which returned 46.6% over the past year.
Return vs Market: 2327 exceeded the Hong Kong Market which returned 20.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Meilleure Health International Industry Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StMeilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue
2 months ago | Simply Wall StMeilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Is Meilleure Health International Industry Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2327 (HK$0.43) is trading below our estimate of fair value (HK$0.95)
Significantly Below Fair Value: 2327 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2327 is poor value based on its PE Ratio (21.8x) compared to the Hong Kong Trade Distributors industry average (12.7x).
PE vs Market: 2327 is poor value based on its PE Ratio (21.8x) compared to the Hong Kong market (11.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2327's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2327 is overvalued based on its PB Ratio (1.3x) compared to the HK Trade Distributors industry average (0.6x).
How is Meilleure Health International Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Meilleure Health International Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Meilleure Health International Industry Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2327 has a large one-off gain of HK$43.9M impacting its December 31 2020 financial results.
Growing Profit Margin: 2327 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 2327's earnings have declined by 6.9% per year over the past 5 years.
Accelerating Growth: 2327 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2327 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Trade Distributors industry (18.1%).
Return on Equity
High ROE: 2327's Return on Equity (6.1%) is considered low.
How is Meilleure Health International Industry Group's financial position?
Financial Position Analysis
Short Term Liabilities: 2327's short term assets (HK$960.2M) exceed its short term liabilities (HK$108.9M).
Long Term Liabilities: 2327's short term assets (HK$960.2M) exceed its long term liabilities (HK$190.7M).
Debt to Equity History and Analysis
Debt Level: 2327's debt to equity ratio (10.7%) is considered satisfactory.
Reducing Debt: 2327's debt to equity ratio has increased from 0.09% to 10.7% over the past 5 years.
Debt Coverage: 2327's debt is well covered by operating cash flow (46.9%).
Interest Coverage: 2327's interest payments on its debt are well covered by EBIT (11.9x coverage).
What is Meilleure Health International Industry Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2327's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2327's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2327's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2327's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2327 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2327's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Wen Chuan Zhou (37 yo)
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...
CEO Compensation Analysis
Compensation vs Market: Wen Chuan's total compensation ($USD103.03K) is below average for companies of similar size in the Hong Kong market ($USD286.39K).
Compensation vs Earnings: Wen Chuan's compensation has been consistent with company performance over the past year.
Experienced Management: 2327's management team is considered experienced (4.9 years average tenure).
Experienced Board: 2327's board of directors are considered experienced (3.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 2327 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Meilleure Health International Industry Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Meilleure Health International Industry Group Limited
- Ticker: 2327
- Exchange: SEHK
- Founded: NaN
- Industry: Trading Companies and Distributors
- Sector: Capital Goods
- Market Cap: HK$1.815b
- Shares outstanding: 4.27b
- Website: https://www.meilleure.com.cn
Number of Employees
- Meilleure Health International Industry Group Limited
- Unit 2906, Tower 1
- Lippo Centre
- Hong Kong
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/22 15:25|
|End of Day Share Price||2021/06/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.